Insulin aspart and Trastuzumab and Hyaluronidase
Determining the interaction of Insulin aspart and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin Aspart
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart-Trastuzumab Injection (Intravenous)
- Insulin aspart-Trastuzumab Intravenous
- Insulin aspart-Trastuzumab-anns
- Insulin aspart-Trastuzumab-dkst
- Insulin aspart-Trastuzumab-dkst Intravenous
- Insulin aspart-Trasylol
- Trastuzumab and Hyaluronidase-Insulin Aspart (Cartridges & Prefilled Pens)
- Trastuzumab and Hyaluronidase-Insulin Aspart (Cartridges & Prefilled Pens) (Fiasp)
- Trastuzumab and Hyaluronidase-Insulin Aspart (Vials)
- Trastuzumab and Hyaluronidase-Insulin Aspart (Vials) (Fiasp)
- Trastuzumab and Hyaluronidase-Insulin aspart and insulin aspart protamine
- Trastuzumab and Hyaluronidase-Insulin aspart and insulin degludec Subcutaneous